NCT07079046Completed
Efficacy of Satisens® in Reducing Emotional Eating
Source: ClinicalTrials.gov · Last updated 22 Jun 2026
Brief summary (registry, in English)
This study evaluates the efficacy of Satisens®, a dietary supplement composed of plant extracts, in reducing emotional eating and sweet cravings in healthy adults. The study will analyze hormonal, neurotransmitter, and inflammatory markers to understand the underlying mechanisms.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 84 (actual)
- First submitted
- 18 Jun 2025
- Start date
- 15 Sept 2025
- Primary completion date
- 18 Dec 2025
- Lead sponsor
- José Enrique de la Rubia Ortí, Ph
- Diseases
- Obesity
- NCT number
- NCT07079046
What you commit to
- Study type: Interventional
- Participants enrolled: 84
- From 15 Sept 2025 to the primary completion date, 18 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Individuals taking medications or supplements that may interfere with study variables
Other
- Pregnant or breastfeeding women
- Individuals engaging in more than 3 hours of active exercise per week
Who the study is looking for
- Adults aged 18 to 65 years
- Healthy individuals without chronic diseases
- Able to provide informed consent
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Universidad Católica de Valencia San Vicente Mártir - Facultad de Medicina y Ciencias de la Salud Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.